Suppr超能文献

儿童髓母细胞瘤。多学科治疗。

Medulloblastoma in childhood. Multidisciplinary treatment.

作者信息

Casotto A, Buoncristiani P

出版信息

Childs Brain. 1982;9(3-4):299-308.

PMID:7105891
Abstract

20 medulloblastomas in children were treated at the Neurosurgical Department of Perugia over the last 6 years. The age ranged between 1.2 and 15 years, with a mean of 8 years. The ratio between males and females was 3/1. Only three tumors were localized within one cerebellar hemisphere. A shunt was performed before the removal of the tumor in 12 cases. Radical resection was completed in 15 cases, whereas a subtotal removal was performed in the cases with involvement of the brain stem. The postoperative mortality rate was 5%. The 3-year survival rate was 40% and the 5-year 25%. The postoperative radiotherapy was given at lower doses than usually reported by other authors: this seems to reduce the neuropsychological and endocrinological sequelae. CCNU of BCNU were given after radiotherapy, but this monochemotherapy seems to be less effective than polychemotherapy with CCNU, vincristine, procarbazine and dexamethasone, used in this series when relapse occurred. Radical resection improved the prognosis. The opportunity of using different protocols for 'low risk' and for 'high risk' patients is finally discussed.

摘要

过去6年里,佩鲁贾神经外科治疗了20例儿童髓母细胞瘤。年龄在1.2岁至15岁之间,平均年龄为8岁。男女比例为3比1。仅3例肿瘤局限于一个小脑半球。12例在切除肿瘤前进行了分流术。15例完成了根治性切除,而脑干受累的病例则进行了次全切除。术后死亡率为5%。3年生存率为40%,5年生存率为25%。术后放疗的剂量低于其他作者通常报道的剂量:这似乎减少了神经心理和内分泌后遗症。放疗后给予洛莫司汀或卡氮芥,但当复发时,这种单一化疗似乎不如本系列中使用的洛莫司汀、长春新碱、丙卡巴肼和地塞米松联合化疗有效。根治性切除改善了预后。最后讨论了针对“低风险”和“高风险”患者使用不同方案的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验